GTx, Inc. (NASDAQ:GTXI)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.

Recs

0
Player Avatar ipsiety (< 20) Submitted: 7/3/2011 2:10:04 AM : Outperform Start Price: $4.73 GTXI Score: -33.84

inisder bought 4.6m worth of shares at 4.75 each. cash rich, zero debt.

Featured Broker Partners


Advertisement